Myasthenia gravis Myasthenia Gravis disorder neuromuscular function premature destruction acetylcholine receptors disease variable weakness repetitive muscular activity administration acetylcholinesterase inhibitors Myasthenia Gravis complex disease many facets natural history immunological basis optimal individual patient management long-term goal control immunological imbalance treatment thymectomy corticosteroids azathioprine plasmapheresis common use acetylcholinesterase inhibitors symptomatic relief variable daily muscular activity Disability due gravis large extent reversible death preventable Early recognition myasthenia gravis appropriate treatment remission permanent 